Submitted by dcc on Fri, 2019-06-14 09:05 Study Title: Pilot Study of Denosumab in BRCA1/2 Mutation Carriers scheduled for Risk-reducing SalpingooophorectomyCIRB: Cancer Prevention and Control CIRBLead Group: CP-CTNet_CLO-MD AndersonStatus: Administratively CompletedReview Status: Completed